CTRI/2024/06/068998
Not yet recruiting
Phase 2
An Open label pilot clinical trial to evaluate the effectiveness of SoothagaMezhugu in the management of Soothaga Vaayu (Poly Cystic Ovarian Syndrome) - NI
il0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- il
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants must meet the diagnostic criteria for Polycystic Ovary Syndrome (PCOS) as per Rotterdam criteria.
- •Women of reproductive age, typically between 18 to 35 years old, should be included.
- •Non\-pregnant participants or those not actively seeking pregnancy should be included.
- •Participants must demonstrate willingness and ability to comply with study requirements, including attending study visits, adhering to treatment protocols, and providing informed consent.
Exclusion Criteria
- •Pregnant women or those actively trying to conceive.
- •Women who have reached menopause or are in the perimenopausal period.
- •Hypothyroidism patients.
- •Participants with significant medical conditions (e.g., uncontrolled diabetes, cardiovascular disease, severe liver or kidney dysfunction).
- •Participants currently using hormonal medications such as oral contraceptives, hormonal replacement therapy, or anti\-androgenic medications should be excluded.
- •Participants with a history of ovarian surgery.
- •Participants currently enrolled in other clinical trials.
- •Individuals lacking the capacity to provide informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Clinical Trial for Diabetic Foot Ulcer through Siddha medicinesHealth Condition 1: E116- Type 2 diabetes mellitus with other specified complicationsCTRI/2023/10/058661ational Institute of Siddha
Completed
Phase 1
A Clinical study on quadrivalent Human Papilloma virus vaccineHealth Condition 1: Z23- Encounter for immunizationCTRI/2017/02/007785Serum Institute of India Pvt Ltd47
Completed
Phase 1
A clinical study to assess safety and tolerability of tetanus, diptheria, and pertussis vaccine in adults.Health Condition 1: Z23- Encounter for immunizationCTRI/2017/03/008003Serum Institute of India Pvt Ltd23
Not yet recruiting
Phase 2
Assesment safety and efficacy of Ayurvedic Formulation AYUSH AGT in external wounds.CTRI/2020/04/024658Central council for Research in Ayurvedic Sciences
Completed
Phase 1
Phase I clinical trial to evaluate the safety,tolerance and immune response ofChikungunya vaccine in healthy adults of 18 to 50 years ageCTRI/2020/04/024533Bharat Biotech International limited20